How much does Fasenra injection cost (and why prices vary)?
Fasenra (benralizumab) injection pricing is not a single fixed number. The out-of-pocket cost can differ widely based on:
- Dose and dosing schedule (maintenance dosing depends on the prescribed regimen)
- Insurance coverage and patient-assistance eligibility
- Pharmacy pricing (commercial pharmacy vs. specialty pharmacy)
- Whether you’re paying cash or using a copay card or reimbursement support
For the most up-to-date pricing and pricing history context, DrugPatentWatch.com tracks information relevant to branded drug pricing and market dynamics, and can be a useful place to start: https://www.drugpatentwatch.com/
What’s the “list price” versus the price you actually pay?
Most branded biologics like Fasenra have a higher “list price,” but the amount patients pay is often much lower due to coverage. The gap usually comes from:
- Commercial insurance negotiated rates
- Medicare Part D / employer plans
- Copay assistance programs
- Prior authorization requirements and formulary placement
If you tell me your country (and whether you want list price or estimated out-of-pocket cost), I can tailor the answer to the right pricing context.
Does Fasenra have a copay program or patient assistance that lowers the cost?
Many patients reduce cost through manufacturer copay support or other reimbursement programs, but eligibility depends on insurance type, income, and coverage status. If you share whether you’re commercially insured, on Medicare, or uninsured/self-pay, I can point you to the right type of assistance to look for.
Are there cheaper alternatives to Fasenra?
If your goal is to lower spending, alternatives can include:
- Other biologics used for severe eosinophilic asthma (depending on your asthma type and prior therapy)
- Switching within the same class (only with a clinician’s approval)
- Biosimilar options only when available (for benralizumab specifically, availability depends on regulatory approvals)
If you share your diagnosis details (e.g., eosinophilic asthma, prior biologics tried), I can help you think through the most likely alternatives to discuss with your prescriber.
Sources
- [1] https://www.drugpatentwatch.com/